Cooley Achieves Top Marks in US, Global M&A and PE Rankings
New York – July 16, 2025 – Cooley’s global mergers and acquisitions and private equity practices were recognized based on their M&A and PE activity on H1 league tables from Bloomberg, Mergermarket and LSEG Data & Analytics.
Cooley’s mergers and acquisitions and private equity practices continue to dominate in public and private transactions in the US and globally – despite the unsettled market.
Cooley’s top rankings by deal count include:
- LSEG,
- #1 on its US M&A league table for completed deals
- #2 on its global M&A league table for completed deals
- #1 on its US M&A league table for completed, target side deals
- Bloomberg,
- #3 on its US M&A league table
- #3 on its global M&A league table
- #3 on its US mid-market M&A
- #3 on its global mid-market M&A
- #3 on its US private equity deals
- #3 on its global private equity deals
- Mergermarket,
- #4 on its US M&A league table
- #5 on its global M&A league table
- #5 on its US private equity buyouts
- #7 on its global private equity buyouts
- #4 on its US private equity exits
- #6 on its global private equity exits
Cooley also received top-tier recognition by deal count across several of our key industry sectors, including:
- Life Sciences,
- #1 rankings for US life sciences M&A (Bloomberg)
- #1 rankings for global life sciences M&A (Bloomberg)
- #1 rankings for US life sciences M&A (Mergermarket)
- #1 rankings for global life sciences M&A (Mergermarket)
- #1 rankings for US life sciences M&A (LSEG)
- #1 rankings for global life sciences M&A (LSEG)
- #2 ranking for public life sciences M&A (Deal Point Data)
- Tech,
- #1 rankings for US tech M&A (Bloomberg)
- #1 rankings for global tech M&A (Bloomberg)
- #2 rankings for US tech M&A (Mergermarket)
- #4 rankings for global tech M&A (Mergermarket)
- #2 rankings for US tech M&A (LSEG)
- #2 rankings for global tech M&A (LSEG)
In 2025, Cooley handled deals across a diverse range of industries while also maintaining its top position in technology and life sciences. Just in the last quarter, the firm handled market-leading transactions representing:
- Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie
- Movable Ink to Be Acquired by STG
- Rubrik Announces Acquisition of Predibase
- Medically Home and DispatchHealth Close Merger
- Heliogen Announces Sale to Zeo Energy
- Tenable to Acquire Apex Security
- Kudu Dynamics Announces $300 Million Sale to Leidos
- Red Canary Announces Acquisition by Zscaler
- SiteOne Therapeutics to Be Acquired by Eli Lilly for up to $1 Billion
- io Products Acquired by OpenAI for $6.5 billion
- Conquer Acquires Full Circle Insights
- BioMarin Acquires Inozyme Pharma
- Gimmal Acquired by Morae Global
- Touchland to Be Acquired by Church & Dwight
- Datadog Acquires Eppo
- JetBlue Sells JetBlue Ventures to SKY Leasing
- Feedzai Acquires Demyst
- Logik.ai Announces Acquisition by ServiceNow
Cooley also advised Dynavax Technologies Corporation on its successful proxy contest against Deep Track Capital.
Since 2020, Cooley’s world-class transactional team has worked on 1,600+ M&A deals for an aggregate value of more than $735 billion – guiding top public and private companies, financial advisors and private equity sponsors in some of the market’s largest and most complex transactions. The mergers and acquisitions and private equity groups include 180+ practitioners in major business and technology centers worldwide, representing all categories of participants in transactions.
* The Bloomberg platform data has not itself been published by Bloomberg.
** The Mergermarket platform data is limited to deals involving at least one party located in North America, Europe, or Asia-Pacific.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.
Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may have been generated with the assistance of artificial intelligence (AI) in accordance with our AI Principles, may be considered Attorney Advertising and is subject to our legal notices.